Antimicrobial activity of the leprostatic drug 3-(p-chloranilino)-10(p-chlorphenyl)-2,10-dihydro-2-(isopropylimino)-phenazine (G 30 320). I. Studies in vitro.
D000596:Amino Acids / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001407:Bacillus / Q000187:drug effects; D001419:Bacteria / Q000187:drug effects*; D002002:Brucella / Q000187:drug effects; D003352:Corynebacterium / Q000187:drug effects; D004352:Drug Resistance, Microbial; D004755:Enterobacteriaceae / Q000187:drug effects; D056890:Eukaryota / Q000187:drug effects*; D005658:Fungi / Q000187:drug effects*; D005947:Glucose / Q000494:pharmacology; D005779:Immunodiffusion; D007538:Isoniazid / Q000494:pharmacology; D008055:Lipids / Q000494:pharmacology; D008837:Micrococcus / Q000187:drug effects; D009163:Mycobacterium bovis / Q000187:drug effects; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D009582:Nitrofurantoin / Q000494:pharmacology; D010619:Phenazines / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D012256:Riboflavin / Q000494:pharmacology; D012710:Serum Albumin, Bovine / Q000494:pharmacology; D013210:Staphylococcus / Q000187:drug effects; D013449:Sulfonamides / Q000494:pharmacology; D013501:Surface-Active Agents / Q000494:pharmacology; D013864:Thioglycolates / Q000494:pharmacology
D000596:Amino Acids; D000900:Anti-Bacterial Agents; D008055:Lipids; D010619:Phenazines; D013449:Sulfonamides; D013501:Surface-Active Agents; D013864:Thioglycolates; D012710:Serum Albumin, Bovine; D009582:Nitrofurantoin; D005947:Glucose; D012256:Riboflavin; D007538:Isoniazid